Scientists have identified the new COVID-19 variant in wastewater in a few U.S. cities. This type of surveillance can help communities stay a step ahead of omicron's spread.
A new survey from the Public Religion Research Institute and the Interfaith Youth Core shows most Americans believe too many people are using religious beliefs as a reason to not get vaccinated.
In small studies in South Africa and in Germany, the results indicate a marked decrease in the ability of vaccines to neutralize this variant. But there are other findings that are encouraging.
Pfizer said Wednesday that a booster dose of its COVID-19 vaccine may protect against the new omicron variant even though the initial two doses appear significantly less effective.
Federal officials are expected to soon greenlight new antiviral pills that could minimize the impact of infection in COVID-19 patients. Dr. David Boulware, a professor of medicine at the University of Minnesota, joined host Cathy Wurzer to share what listeners should know about the new drugs.
A COVID-19 vaccine from a Canadian biotech firm has been found effective at preventing moderate to severe disease. It could soon become the first plant-based vaccine authorized for human use.
Omicron has many more mutations than previous variants of concern, a fact that raises questions about how effective existing vaccines will be against the new form of the coronavirus.
State officials worried about a possible bounce from the Thanksgiving holiday, which brought many together indoors for celebrations — the kind of conditions that lead to more viral spread. That appears to be happening.
As he prepares to leave his post of 12 years, Francis Collins reflects on the agency's biomedical advances, the dangers of polarizing medicine, and the huge health gaps that still exist in the U.S.